Spinout Active LTD

Company profile

Orbit Discovery Ltd

Orbit Discovery Delivering Peptide Enabled Drug Discovery Solutions

Orbit Discovery Ltd is a UK company with status active founded in 2020 based in South East England.

CRN
12850396
Founded
2020
Age
5

Overview

Browse spinouts
Legal name
ORBIT DISCOVERY LTD
Region
South East England
Registered address
INVENTA BUILDING
BOTLEY ROAD
OXFORD
ENGLAND
OX2 0HA
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

2 levels 1 ultimate controller
1
Company Active LTD
Orbit Discovery Ltd
CRN 12850396
2
Direct controller Active LTD
3
Ultimate controller Active PLC

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Jun
2027

Accounts due

Accounts Due

Next accounts due date

14 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2025

Accounts filed

Accounts

Last accounts made up date

31 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

11 Sep
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzNTI2OTUxN2FkaXF6a2N4

Published 11 Sep 2024 10:37

01 Sep
2020

Incorporated

Inception

Company registered at Companies House

Spinout profile

1 entry

Company description

Peptide drug discovery company

Project impact

None yet

Orbit Discovery Ltd
2015

Public funding

2 awards
First funded
2022
Funded years
2022, 2024
Age at first award
1 years

Projects

2024 Collaborative R&D

Novel technology platforms for computational design and cell-based screening of peptide libraries targeting orphan GPCRs

1 Apr 2024 to 31 Mar 2026

Awarded
£409,938
Total cost £585,625

ProteinQure and Orbit Discovery are developing a new peptide discovery platform that can be commercialized as well as specific therapeutic molecules addressing key unmet needs. In particular we aim to develop novel peptide ligands using ProteinQure's Artificial Intelligence (AI) Platform to design custom libraries which will be subsequently utilised in fu...

2022 Collaborative R&D Lead participant

High throughput cell-based functional screening platform for peptide drug discovery

1 Jun 2022 to 30 Nov 2023

Awarded
£330,980
Total cost £472,828

Orbit Discovery is a UK-based SME pioneering the discovery and development of novel peptide therapeutics. Peptides represent a unique class of pharmaceutical compound, having incredibly high chemical diversity, molecularly poised between small molecules and proteins, yet biochemically and therapeutically distinct from both. Peptide therapeutics typically ...

Product types

Collaborative R&D